News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Markets showed limited movement as no economic data or corporate announcements were released this hour.
  • No central bank statements or policy actions occurred in the past hour.
  • No geopolitical events or security incidents were reported this hour.
  • No earnings, mergers, or corporate filings appeared in the last hour.
  • Commodity and oil markets lacked fresh supply or demand drivers and remained quiet this hour.
  • US and European political calendars had no floor votes or legislative developments this hour.

Latest Articles

Mobilicom to Unveil New Solution and Showcase Cybersecure Portfolio at AUSA 2026; Company to Present at ThinkEquity Investor Conference

Mobilicom to Unveil New Solution and Showcase Cybersecure Portfolio at AUSA 2026; Company to Present at ThinkEquity Investor Conference

Mobilicom Limited announced its participation at AUSA 2026 where it will showcase a new cybersecure communication solution designed for autonomous defense operations, addressing increasing data demands. Additionally, the company will present its business and growth opportunities in the drone, robotics, and defense sectors at the ThinkEquity investo…

Buy Ironwood (IRWD): A Leverage Play on the Second Apraglutide Trial

Buy Ironwood (IRWD): A Leverage Play on the Second Apraglutide Trial

Ironwood is a small-cap biotech trading at bargain multiples backed by solid LINZESS economics and meaningful free cash flow. The stock is fundamentally a call on the company executing and advancing a second Phase 3 apraglutide trial requested by regulators. If the company proves the program is on track, the re-rating can be substantial; failure or…

OR Royalties: Cash-Heavy Growth Profile and Tactical Long at $34.47

OR Royalties: Cash-Heavy Growth Profile and Tactical Long at $34.47

OR Royalties reported Q3 deliveries of 20,237 GEOs and $90.2M of revenue with a cash margin of 96.8%, left $76.7M of cash on the balance sheet, and still has significant available lending capacity. The stock trades at $34.47, well below a 52-week high of $48.06; we see tactical upside to $40.00 on continued GEO delivery growth, accretive small acqu…

Sportradar Announces Agreement for the Divestiture of Coaching and Scouting Business of Synergy Sports to Teamworks Innovations

Sportradar Announces Agreement for the Divestiture of Coaching and Scouting Business of Synergy Sports to Teamworks Innovations

Sportradar Group AG announced an agreement to sell Atrium Sports, the coaching and scouting segment of Synergy Sports, to Teamworks Innovations for $170 million in cash. This divestiture allows Sportradar to streamline its business and concentrate on its principal betting, gaming, and media operations while retaining key technology assets. The tran…

Crane NXT Appoints Jeong H. Kim to Board of Directors

Crane NXT Appoints Jeong H. Kim to Board of Directors

Crane NXT, a global leader in authentication and traceability technologies, announced the appointment of Jeong H. Kim to its Board of Directors effective October 29, 2026. Dr. Kim brings extensive leadership experience in advanced technologies and commercializing innovations, expected to support Crane NXT's growth and market leadership.

Atlantic HPC Group Inc Appoints Leo Lin as Chief Executive Officer

Atlantic HPC Group Inc Appoints Leo Lin as Chief Executive Officer

Atlantic HPC Group Inc, a U.S.-based digital infrastructure company focused on bitcoin mining, announced the appointment of Leo Lin as its new CEO effective October 1, 2026. Lin brings over 20 years of executive experience, including leadership roles in tech and finance sectors. The company is planning to expand its operations from bitcoin mining t…

Beam Global Signs Definitive Agreement to Acquire Drone Technology Company ScoutDI, Creating a Vertically Integrated U.S. Drone Platform for Industrial and Defense Markets

Beam Global Signs Definitive Agreement to Acquire Drone Technology Company ScoutDI, Creating a Vertically Integrated U.S. Drone Platform for Industrial and Defense Markets

Beam Global has signed a definitive agreement to acquire Norway-based drone technology company ScoutDI for approximately $24 million. The acquisition aims to establish Beam as a vertically integrated U.S. drone manufacturer with capabilities in energy, mobility, and defense markets. ScoutDI's drone systems, including those with conditional U.S. Dep…

BrewDog Rallies Beer Lovers Across the UK to Choose Craft

BrewDog Rallies Beer Lovers Across the UK to Choose Craft

BrewDog, owned by Tilray Brands, is spearheading a UK-wide campaign called 'Choose Craft' to revitalize the craft beer market. The campaign celebrates quality ingredients, flavor, and the craft beer community, driving a 2.87x sales increase in key products. BrewDog also secured eight new on-trade partnerships, expanding its footprint in entertainme…

Farmers & Merchants (FMAO): Rising Margins Could Push Shares Toward $42

Farmers & Merchants (FMAO): Rising Margins Could Push Shares Toward $42

FMAO looks cheap for a regional with $3.4B+ in assets, a $487M market cap, and improving profitability. Rising net interest margin (industry tailwinds plus local loan growth), a history of dividend increases and a conservative balance sheet create room for a re-rate to a mid-teens P/E. Entry at $35.40, target $42.00, stop $31.00 for a long-term (18…

Caspian Therapeutics and Kura Oncology to Host Investor Webcast Highlighting Caspian’s Launch and KO-7246 Preclinical Data in Diabetes

Caspian Therapeutics and Kura Oncology to Host Investor Webcast Highlighting Caspian’s Launch and KO-7246 Preclinical Data in Diabetes

Caspian Therapeutics, formed from menin-inhibitor research at Kura Oncology, is advancing KO-7246, a novel oral menin inhibitor aimed at treating diabetes by restoring beta-cell function. Kura Oncology and Caspian will present preclinical data at an upcoming investor webcast, highlighting progress and potential applications of this therapy in cardi…

OrthoPediatrics Expands Its Lower Extremity Bracing Portfolio with the Launch of OPSB® Knee 'TractorFIX

OrthoPediatrics Expands Its Lower Extremity Bracing Portfolio with the Launch of OPSB® Knee 'TractorFIX

OrthoPediatrics Corp. announced the launch of the OPSB® Knee 'TractorFIX, a pioneering pediatric bracing solution designed to manage knee contractures in young patients undergoing tibial treatment with external fixators. This new product expands their specialty bracing portfolio, offering a standardized alternative to custom-built solutions and int…

Zenas BioPharma Announces Upcoming Presentations of Orelabrutinib Data in Relapsing Remitting Multiple Sclerosis, Clinical Trial Designs in Progressive Multiple Sclerosis and Other Multiple Sclerosis Portfolio Data at MSToronto2026

Zenas BioPharma Announces Upcoming Presentations of Orelabrutinib Data in Relapsing Remitting Multiple Sclerosis, Clinical Trial Designs in Progressive Multiple Sclerosis and Other Multiple Sclerosis Portfolio Data at MSToronto2026

Zenas BioPharma announces presentations of clinical data for Orelabrutinib and Obexelimab across multiple sclerosis subtypes at MSToronto2026 conference, highlighting progress in late-stage trials and potential new therapies for progressive MS with unmet needs.

OR Royalties Announces Preliminary Q3 2026 GEO Deliveries

OR Royalties Announces Preliminary Q3 2026 GEO Deliveries

OR Royalties Inc. announced its preliminary third quarter 2026 results, earning 20,237 gold equivalent ounces and generating revenues of $90.2 million with a high cash margin of 96.8%. The company also completed a $15 million royalty acquisition during the quarter and maintains a strong cash position of $76.7 million. The revolving credit facility …

Marex announces changes to Group Board

Marex announces changes to Group Board

Marex Group Limited announced that Robert Pickering has stepped down as Chair of the Board after overseeing significant growth, including the company's IPO on Nasdaq in April 2024. John Pietrowicz, former CFO of CME Group and current Board member, has succeeded him as Chair, bringing valuable expertise in financial markets and mergers and acquisiti…

Arvinas Shares Novel Oculomotor and Biomarker Data from Phase 1 Clinical Trial of ARV-102 in Patients with Parkinson’s Disease

Arvinas Shares Novel Oculomotor and Biomarker Data from Phase 1 Clinical Trial of ARV-102 in Patients with Parkinson’s Disease

Arvinas, Inc. announced final data from its Phase 1 clinical trial of ARV-102, a PROTAC degrader targeting LRRK2, in Parkinson’s disease patients. The trial demonstrated that ARV-102 crosses the blood-brain barrier, reduces LRRK2 protein levels in cerebrospinal fluid, and leads to improvements in oculomotor function and biomarkers related to neurod…